Literature DB >> 17870429

Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions.

Alan C Geller1, Susan M Swetter, Katie Brooks, Marie-France Demierre, Amy L Yaroch.   

Abstract

UNLABELLED: In the past 5 years, there have been notable strides toward the earlier recognition and discovery of melanoma, including new technologies to complement and augment the clinical examination and new insights to help clinicians recognize early melanoma. However, incidence and mortality rates throughout most of the developed world have risen over the past 25 years, while education and screening, potentially the best means for reducing the disease, continue to be severely underutilized. Much progress needs to be made to reach middle-aged and older men and persons of lower socioeconomic status who suffer a disproportionate burden of death from melanoma. Worldwide melanoma control must also be a priority, and comprehensive educational and screening programs should be directed to Northern Ireland and a number of Eastern European nations, whose 5-year survival rates range between 53% and 60%, mirroring those of the United States and Australia more than 40 years ago. LEARNING
OBJECTIVE: After completing this learning activity, participants should be aware of the most recent melanoma epidemiologic data, both in the United States and internationally; worldwide early detection and screening programs; clinical strategies to recognize and improve the detection of early melanoma; the latest technologies for early detection of melanoma; and public and professional education programs designed to enhance early detection.

Entities:  

Mesh:

Year:  2007        PMID: 17870429     DOI: 10.1016/j.jaad.2007.06.032

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  47 in total

1.  MMP2 expression is a prognostic marker for primary melanoma patients.

Authors:  Anand Rotte; Magdalena Martinka; Gang Li
Journal:  Cell Oncol (Dordr)       Date:  2012-06-06       Impact factor: 6.730

2.  The expanding melanoma burden in California hispanics: Importance of socioeconomic distribution, histologic subtype, and anatomic location.

Authors:  Ricardo A Pollitt; Christina A Clarke; Susan M Swetter; David H Peng; John Zadnick; Myles Cockburn
Journal:  Cancer       Date:  2010-08-24       Impact factor: 6.860

3.  Unusual documentation of the transformation of a nevus into malignant melanoma.

Authors:  Lindasusan Marcus; Robert Carlin; Neal Carlin
Journal:  J Clin Aesthet Dermatol       Date:  2009-01

Review 4.  Strategies for early melanoma detection: Approaches to the patient with nevi.

Authors:  Agnessa Gadeliya Goodson; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2009-05       Impact factor: 11.527

5.  Developing an interactive web-based learning program on skin cancer: the learning experiences of clinical educators.

Authors:  Waqas R Shaikh; Alan Geller; Gwen Alexander; Maryam M Asgari; Gunther J Chanange; Stephen Dusza; Melody J Eide; Suzanne W Fletcher; Jacqueline M Goulart; Allan C Halpern; Shoshana Landow; Ashfaq A Marghoob; Elizabeth A Quigley; Martin A Weinstock
Journal:  J Cancer Educ       Date:  2012-12       Impact factor: 2.037

6.  Knowledge, perceptions, and practices of chiropractic interns in the early detection of atypical moles.

Authors:  Michael Ramcharan; Marion Willard Evans; Harrison Ndetan; Jennifer Beddard
Journal:  J Chiropr Med       Date:  2011-04-05

7.  Piloting the Use of Smartphones, Reminders, and Accountability Partners to Promote Skin Self-Examinations in Patients with Total Body Photography: A Randomized Controlled Trial.

Authors:  Andrew J Marek; Emily Y Chu; Michael E Ming; Zeeshan A Khan; Carrie L Kovarik
Journal:  Am J Clin Dermatol       Date:  2018-10       Impact factor: 7.403

8.  "It's Not JUST Skin Cancer": Understanding Their Cancer Experience From Melanoma Survivor Narratives Shared Online.

Authors:  Smita C Banerjee; Thomas A D'Agostino; Mallorie L Gordon; Jennifer L Hay
Journal:  Health Commun       Date:  2016-12-16

9.  P-cadherin counteracts myosin II-B function: implications in melanoma progression.

Authors:  Koen Jacobs; Mireille Van Gele; Ramses Forsyth; Lieve Brochez; Barbara Vanhoecke; Olivier De Wever; Marc Bracke
Journal:  Mol Cancer       Date:  2010-09-22       Impact factor: 27.401

10.  Time-trend of melanoma screening practice by primary care physicians: a meta-regression analysis.

Authors:  Antonis Valachis; Davide Mauri; Vassiliki Karampoiki; Nikolaos P Polyzos; Ivan Cortinovis; Georgios Koukourakis; Georgios Zacharias; Apostolos Xilomenos; Maria Tsappi; Giovanni Casazza
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.